Responses
Immune cell therapies and immune cell engineering
Original research
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
Compose a Response to This Article
Other responses
No responses have been published for this article.